Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Healthcare Company (ACHC) Operating Leases (2019 - 2025)

Acadia Healthcare Company (ACHC) has disclosed Operating Leases for 7 consecutive years, with $95.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Leases fell 9.46% to $95.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $95.5 million, a 9.46% decrease, with the full-year FY2024 number at $101.8 million, up 1.01% from a year prior.
  • Operating Leases was $95.5 million for Q3 2025 at Acadia Healthcare Company, up from $94.7 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $120.6 million in Q1 2022 to a low of $83.7 million in Q1 2021.
  • A 5-year average of $104.8 million and a median of $104.0 million in 2024 define the central range for Operating Leases.
  • Peak YoY movement for Operating Leases: plummeted 81.16% in 2021, then surged 43.98% in 2022.
  • Acadia Healthcare Company's Operating Leases stood at $116.8 million in 2021, then decreased by 0.35% to $116.4 million in 2022, then fell by 13.42% to $100.8 million in 2023, then increased by 1.01% to $101.8 million in 2024, then decreased by 6.25% to $95.5 million in 2025.
  • Per Business Quant, the three most recent readings for ACHC's Operating Leases are $95.5 million (Q3 2025), $94.7 million (Q2 2025), and $101.3 million (Q1 2025).